comparemela.com

Latest Breaking News On - Kubota pharmaceutical holdings - Page 5 : comparemela.com

Space Force, Full Moon Discovery, Killer AI and More Mysterious News Briefly — January 29, 2021

Mysterious News Briefly January 29, 2021 A new Canadian study found that some cannabis strains developed in a lab help reduce a specific type of inflammatory distress called a “cytokine storm” that precedes severe cases of acute respiratory distress due to Covid-19. If you’ve got Covid-19, you won’t be able to taste the brownies, but who cares? Trillions of cicadas are set to emerge across 15 U.S. states this spring after ending their 17-year-long underground hibernation and entering a brief life of molting, flying, mating and incredibly loud chirping. This would be a good time to invest in companies that make earplugs and heavy-duty windshield wipers.

Japanese Company Creates Smart Glasses That Can Allegedly Cure Myopia

Japanese Company Creates “Smart Glasses” That Can Allegedly Cure Myopia Japan’s Kubota Pharmaceutical Holdings claims to have developed smart glasses that, if worn just an hour per day, can allegedly cure myopia. Myopia, or nearsightedness, is a common ophthalmological condition in which you can see objects near to you clearly, but objects farther away are blurry. To compensate for this blur, you have the option of wearing eyeglasses or contact lenses, or the more invasive refractive surgery. But a Japanese company claims to have come up with a new non-invasive way of dealing with myopia – a pair of “smart glasses” that project an image from the lens of the unit onto the wearer’s retina to correct the refractive error that causes nearsightedness. Apparently, wearing the device 60 to 90 minutes a day corrects myopia.

Kubota Vision Provides Update on Kubota Glasses Wearable Device for Myopia Control

Posted on 530 Kubota Vision Inc. (Kubota Vision), a clinical-stage specialty ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), today announced that the company achieved a milestone by completing a first spectacle-style wearable prototype based on Kubota Glasses technology. (1) Kubota Vision conducted a clinical study in early 2020 with an electronic tabletop optical projection device that embodied Kubota Glasses technology; (2) The company also completed a successful proof-of-concept (POC) clinical study to validate the concept of a wearable myopia-control device based on Kubota Glasses technology in August 2020; (3) Based on these results, the company has completed the first spectacle-style wearable prototype based on Kubota Glasses technology. (Photo: Business Wire)

かけるだけで近視を治す「クボタメガネ」プロトタイプが完成--商業化に向け

かけるだけで近視を治す「クボタメガネ」プロトタイプが完成--商業化に向け
cnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cnet.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.